| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.04 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |